Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Which Patients Would Most Likely to Benefit: MIGS or MEGS, Which One Is It?

Which Patients Would Most Likely to Benefit: MIGS or MEGS, Which One Is It? Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/04/2020 PERSPECTIVES Which Patients Would Most Likely to Benefit: MIGS or MEGS, Which One Is It? Huda Sheheitli, MD y, Aubrey R. Tirpack, MD z, and Richard K. ParrishII, MD This intervention was proposed to address the problems of Abstract: The availability of ab interno minimally invasive glaucoma adherence to medical therapy, and to minimize the adverse events surgery (MIGS) has promoted an international interest in this procedure. and quality of life issues related to topical glaucoma medications. Our purpose is to define the role of MIGS in the constant evolving As opposed to traditional glaucoma procedures that are indicated glaucoma treatment algorithm. Current MIGS approaches to lowering in advanced or medically uncontrolled glaucoma, MIGS devices intraocular pressure (IOP) include increasing trabecular outflow (iStent were intended for earlier use in the glaucoma treatment algorithm. trabecular microbypass stent, iStent inject, Hydrus Microstent, Kahook Newer MIGS devices have been used in patients with severe or Dual Blade goniotomy, Trabectome ab interno trabeculectomy, Excimer refractory glaucoma and uncontrolled IOP, including those with laser trabeculotomy, and goniotomy-assisted transluminal trabeculot- 5–8 history of previous failed glaucoma surgery. As the number omy), increasing uveoscleral outflow with suprachoroidal shunts (Cypass http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Asia-Pacific Journal of Ophthalmology Wolters Kluwer Health

Which Patients Would Most Likely to Benefit: MIGS or MEGS, Which One Is It?

Loading next page...
 
/lp/wolters-kluwer-health/which-patients-would-most-likely-to-benefit-migs-or-megs-which-one-is-l8I6b7kIKc
Publisher
Wolters Kluwer Health
ISSN
2162-0989
eISSN
2475-5028
DOI
10.1097/APO.0000000000000260
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/apjoo by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/04/2020 PERSPECTIVES Which Patients Would Most Likely to Benefit: MIGS or MEGS, Which One Is It? Huda Sheheitli, MD y, Aubrey R. Tirpack, MD z, and Richard K. ParrishII, MD This intervention was proposed to address the problems of Abstract: The availability of ab interno minimally invasive glaucoma adherence to medical therapy, and to minimize the adverse events surgery (MIGS) has promoted an international interest in this procedure. and quality of life issues related to topical glaucoma medications. Our purpose is to define the role of MIGS in the constant evolving As opposed to traditional glaucoma procedures that are indicated glaucoma treatment algorithm. Current MIGS approaches to lowering in advanced or medically uncontrolled glaucoma, MIGS devices intraocular pressure (IOP) include increasing trabecular outflow (iStent were intended for earlier use in the glaucoma treatment algorithm. trabecular microbypass stent, iStent inject, Hydrus Microstent, Kahook Newer MIGS devices have been used in patients with severe or Dual Blade goniotomy, Trabectome ab interno trabeculectomy, Excimer refractory glaucoma and uncontrolled IOP, including those with laser trabeculotomy, and goniotomy-assisted transluminal trabeculot- 5–8 history of previous failed glaucoma surgery. As the number omy), increasing uveoscleral outflow with suprachoroidal shunts (Cypass

Journal

The Asia-Pacific Journal of OphthalmologyWolters Kluwer Health

Published: Nov 1, 2019

There are no references for this article.